Afya Limited (NASDAQ:AFYA) Plans Annual Dividend of $0.66

Afya Limited (NASDAQ:AFYA) declared an annual dividend on Thursday, March 12th, NASDAQ Dividends reports. Investors of record on Wednesday, March 25th will be given a dividend of 0.656 per share on Monday, April 6th. This represents a yield of 460.0%. The ex-dividend date is Wednesday, March 25th.

Afya has a payout ratio of 12.0% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Afya to earn $1.91 per share next year, which means the company should continue to be able to cover its $0.23 annual dividend with an expected future payout ratio of 12.0%.

Afya Price Performance

Shares of AFYA opened at $14.69 on Monday. The firm has a market cap of $1.38 billion, a PE ratio of 10.06, a price-to-earnings-growth ratio of 0.66 and a beta of 0.52. Afya has a 52-week low of $13.00 and a 52-week high of $19.90. The business’s 50 day moving average price is $14.34 and its two-hundred day moving average price is $14.74. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.98 and a current ratio of 2.20.

Afya (NASDAQ:AFYA) last released its quarterly earnings data on Thursday, March 12th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.05. Afya had a net margin of 20.31% and a return on equity of 18.77%. The company had revenue of $147.08 million during the quarter, compared to analyst estimates of $174.74 million. On average, equities analysts anticipate that Afya will post 1.52 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the stock. Sanford C. Bernstein upgraded shares of Afya to a “market perform” rating in a report on Friday, January 16th. JPMorgan Chase & Co. reissued a “neutral” rating and set a $22.00 target price (down from $24.50) on shares of Afya in a research report on Wednesday, January 7th. UBS Group reaffirmed a “neutral” rating and issued a $16.00 price target (down from $18.00) on shares of Afya in a research report on Friday, January 16th. Weiss Ratings reiterated a “hold (c)” rating on shares of Afya in a research note on Wednesday, January 21st. Finally, Bank of America lowered Afya from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $22.00 to $17.00 in a report on Tuesday, February 24th. One equities research analyst has rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $17.30.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.